Prophylaxis of thromboembolism

Authors: M. Penka
Authors‘ workplace: OKH FN Brno ;  Interní hematologická a onkologická klinika ;  Společná pracoviště s FN Brno – pracoviště medicíny dospělého věku
Published in: Geriatrie a Gerontologie 2013, 2, č. 4: 206-209
Category: Review Article


Despite diagnostic, prophylactic and therapeutical progression remains venous thromboembolism important healthy and social problem. The emphasis is contemporary set on extensive preventive and prophylactic proceeding and the algoritms are worked out to provide the care in specific situations. Nevertheless, venous thromboembolism in Europe is the cause of death in more than 500 000 people each year.

thrombosis – embolism – prophylaxis – heparin – warfarin


1. Geerts W: Prevention of venous thromboembolism: a key patient safety priority. JTH 2009; Suppl. 1: 1–8.

2. Cohen AT, Tapson VF, Bergmann JF et al.: Venous thromboembolic risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 2008; 371: 387–394.


4. Seligsohn U, Lubetsky A: Genetic Susceptibility to Venous Thrombosis. N Engl J Med 2001; 344 (16): 1222–1231.

5. Hettiarachchi, Lok J, Prins MH, Bueller HR, Prandoni P: Undiagnosed Malignancy in Patients with Deep Vein Thrombosis, Incidence, Risk factors, and Diagnosis. Cancer 1998; 83(1): 180–185.

6. Kvasnička J: Trombofilie a trombotické stavy v klinické praxi. Grada Publishing 2003: 13–299.

7. Widimský J, Malý J a kol.: Akutní plicní embolie a žilní trombóza. Triton 2002: 7–303.

8. Kucher N, Koo S, Quirit R et al: Electronic alerts to prevent venous thrombembolism among hospitalised patients. N Engl J Med 2005; 352: 969–977.

9. Antithrombotic and thrombolytic therapy. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (9th Edition), Chest, 2012; 141/2: 7S–48S.



12. Krška Z: Trombembolická nemoc v chirurgii, Trendy soudobé chirurgie svazek 2, Galén Praha, 1998: 1–165.

13. Kakkar VV, Lorenzo F: Prevention of venous thromboembolism in ge-neral surgery. Clinical Haematology 1998, 11(2): 605–619.

14. Jaenecke J: Indikationsgebiete fur Antikoagulantien. Post- und praeoperative Antikoagulantienprophylaxe Antikoagulanzien und Fibrinolzsetherapie. Georg Thieme Verlag. Stuttgart-New York 1996: 142–175.

15. Hull RD, Pineo GF, Francis Ch et al.: Low-Molecular-Weight Heparin Prophylaxis Using Dalteparin Extended Out-of-Hospital vs In-Hospital Warfarin/Out-of-Hospital Placebo in Hip Arthroplasty Patients. Original Investigation. Arch. Intern. Med 2000; 160: 2208–2215.

16. van Gorp ECM, Brandjes DPM, Cate J: Rational Antithrombotic Therapy and Prophylaxis in Elderly, Immobile Patients. Drugs & Aging 1998; 13(2): 145–157.

17. Kessler P: Léčba orálními antikoagulancii. Orion, Praha 2002: 1–62.

18. Hirsh J, Fuster V, Ansell J, Halperin JL: American Heart Association/American College of Cardiology Foundation Guide to Warfarin therapy, Ciculation 2003; 107: 1692–1711.

19. Berkowitz SD, Marder VJ, Kosutic G, Baugchman: Oral heparin administration with a novel drug delivery agent (SNAC) in healthy volunteers and patients undergoing elective total hip arthroplasty. Journal of Thrombosis and Haemostasis 2003; 1: 1914–1919.

Geriatrics General practitioner for adults Orthopaedic prosthetics
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.


Don‘t have an account?  Create new account